Impact of experimental peritonitis on bone marrow cell function

Surgery

Volumn 126, Issue 1, 1999, Pages 41-47

  Barthlen, Winfried ^a   Zantl, Nikolaus ^a   Pfeffer, Klaus ^a   Heidecke, Claus Dieter ^a   Holzmann, Bernhard ^a   Stadler, Joseph ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASCENDING COLON; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; INFLAMMATION; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; SEPSIS; STENT;

EID: 0032810991     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.1999.99060     Document Type: Article

References (20)

1. 1. Katayama N, Clark SC, Ogawa M. Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood 1993;81,3:610-6.
2. 2. Abello PA, Fidler SA, Bulkley GB, Buchman TG. Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch Surg 1994;129:134-41.
3. 3. Cotter TG, Lennon SV, Glynn JM, Green DR. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res 1992;52:997-1005.
4. 4. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
5. 5. Mammen EF. The haematological manifestations of sepsis. J Antimicrob Chemother 1998;41:17-24.
6. 6. Gottlieb DJ, Cryz SJ, Furer E, et al. Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients. Blood 1990;76,12:2470-5.
7. 7. Cornacchione P, Scaringi L, Fettucciari K, et al. Group B streptococci persist inside macrophages. Immunology 1998;93,1:86-95.
8. 8. Zantl N, Uebe A, Neumann B, et al. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun 1998;66,5:2300-9.
9. 9. Hensler T, Heidecke CD, Hecker H, et al. Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol 1998;161:2655-9.
10. 10. Curran RD, Billiar TR, Stuehr DJ, et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 1990;212, 4:462-71.
11. 11. Hahn PY, Wang P, Tait SM, Ba ZF, Reich SS, Chaudry IH. Sustained elevation in circulating catecholamine levels during polymicrobial sepsis. Shock 1995;4,4:269-73.
12. 12. Iversen PO, Nicolaysen G, Benestad HB. Endogenous nitric oxide causes vasodilation in rat bone marrow, bone, and spleen during accelerated hematopoiesis. Exp Hematol 1994;22,13:1297-302.
13. 13. Wong JM, Billiar TR. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Adv Pharmacol 1995;34:155-69.
14. 14. Maciejewski JP, Selleri C, Sato T, Cho HJ, Keefer LK, Nathan CF. Nitric oxide suppression of human hematopoiesis in vitro. J Clin Invest 1995;96:1085-92.
15. + bone marrow cells in relation to their colony formation. Blood 1993;81:3214-6.
16. 16. Feder LS, Laskin DL. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF and IL-1β following acute endotoxemia. J Leukoc Biol 1994;55:507-13.
17. 17. Khwaja A, Carver J, Jones HM, Paterson D, Linch DC. Expression and dynamic modulation of the human granulocyte colony-stimulating factor receptor in immature and differentiated myeloid cells. Br J Haematol 1993;85:254-9.
18. 18. Warren HS. Strategies for the treatment of sepsis. N Engl J Med 1997;336:952-3.
19. 19. Wang CQ, Udupa KB, Lipschitz DA. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J Cell Physiol 1995;162:134-8.
20. 20. Selleri C, Maciejewski JP, Sato T, Young NS. Interferon-γ constitutively epressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 1996;87:4149-57.